Leonards Schleifer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Leonards schleifer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Leonards Schleifer Today - Breaking & Trending Today

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) CEO Sells $9,203,857.52 in Stock

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) CEO Leonard S. Schleifer sold 9,064 shares of Regeneron Pharmaceuticals stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $1,015.43, for a total transaction of $9,203,857.52. Following the transaction, the chief executive officer now owns 55,134 shares […] ....

Leonards Schleifer , Catalyst Capital Advisors , E Fund Management Co , Hedge Funds Weigh In On Regeneron Pharmaceuticals , Cantor Fitzgerald , Regeneron Pharmaceuticals Stock Down , News Ratings For Regeneron Pharmaceuticals Daily , Quarter For Regeneron Pharmaceuticals , Fund Management Co , Royal Bank , Fiera Capital Corp , Regeneron Pharmaceuticals , Capital Investment Advisors , Regeneron Pharmaceuticals Inc , Get Free Report , Pharmaceuticals Stock Down , Capital Corp , Capital Advisors , Fund Management , Regeneron Pharmaceuticals Daily ,

Insider Selling: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) CEO Sells 9,064 Shares of Stock

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) CEO Leonard S. Schleifer sold 9,064 shares of Regeneron Pharmaceuticals stock in a transaction on Tuesday, June 11th. The stock was sold at an average price of $1,015.43, for a total transaction of $9,203,857.52. Following the sale, the chief executive officer now directly owns 55,134 shares of […] ....

Sanfordc Bernstein , Leonards Schleifer , Morgan Stanley , Quarter For Regeneron Pharmaceuticals , News Ratings For Regeneron Pharmaceuticals Daily , Cantor Fitzgerald , Royal Bank , Norges Bank , Regeneron Pharmaceuticals Inc , International Assets Investment Management , Capital International Investors , Regeneron Pharmaceuticals , Global Assets Advisory , Regeneron Pharmaceuticals Stock Performance , Get Free Report , Assets Investment Management , Assets Advisory , International Investors , Truist Financial , Regeneron Pharmaceuticals Daily ,

Forefront Analytics LLC Buys 26 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Forefront Analytics LLC boosted its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 8.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 319 shares of the biopharmaceutical company’s stock after buying an additional 26 shares during the period. Forefront Analytics LLC’s […] ....

United States , Hong Kong , Michaels Brown , Sanfordc Bernstein , Leonards Schleifer , Quarter For Regeneron Pharmaceuticals , Securities Exchange Commission , Royal Bank , Regeneron Pharmaceuticals , Regeneron Pharmaceuticals Price Performance , Nebula Research Development , Morgan Stanley , Forefront Analytics , Regeneron Pharmaceuticals Company Profile , Hong Kong Ltd , Regeneron Pharmaceuticals Inc , News Ratings For Regeneron Pharmaceuticals Daily , Caxton Associates , Free Report , Asset Managment , Kong Ltd , Partners Management , Nebula Research , Get Free Report , Director Michael , Exchange Commission ,

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Avidity Partners Management LP

Avidity Partners Management LP grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 17.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 68,000 shares of the biopharmaceutical company’s stock after purchasing an additional 10,000 shares during the period. Regeneron Pharmaceuticals […] ....

United States , Sanfordc Bernstein , Leonards Schleifer , News Ratings For Regeneron Pharmaceuticals Daily , Regeneron Pharmaceuticals Inc , Quarter For Regeneron Pharmaceuticals , Capital Management Inc , Regeneron Pharmaceuticals Price Performance , Morgan Stanley , Wealth Management , Cantor Fitzgerald , Regeneron Pharmaceuticals , Trinitypoint Wealth , Securities Exchange Commission , Eudaimonia Advisors , Avidity Partners Management , Free Report , Partners Management , Management Inc , Point Wealth , Exchange Commission , Get Free Report , Visit Holdingschannel , Regeneron Pharmaceuticals Daily ,

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Tower Research Capital LLC TRC

Tower Research Capital LLC TRC lifted its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 259.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 18,553 shares of the biopharmaceutical company’s stock after acquiring an additional 13,392 shares during the period. Tower Research Capital LLC TRC’s holdings in Regeneron Pharmaceuticals […] ....

Sanfordc Bernstein , Leonards Schleifer , Andrewj Murphy , Regeneron Pharmaceuticals Inc , Fortitude Family Office , Cantor Fitzgerald , Bruceg Allen Investments , News Ratings For Regeneron Pharmaceuticals Daily , Regeneron Pharmaceuticals Price Performance , Securities Exchange Commission , Tower Research Capital , Regeneron Pharmaceuticals , Quarter For Regeneron Pharmaceuticals , Annis Gardner Whiting Capital Advisors , Criterion Capital Advisors , Holdings Channel , Free Report , Research Capital , Gardner Whiting Capital Advisors , Family Office , Capital Advisors , Exchange Commission , Get Free Report , Visit Holdingschannel , Regeneron Pharmaceuticals Daily ,